ALL

Serge Hancharevich, Managing Partner of Capital Times, spoke at the final of the CGPA Corporate Director program

Serge Hancharevich Managing Partner of Capital Times, spoke at the final of the CGPA Corporate Director program Last week, the final of the CGPA Corporate Director program was held in the form of a simulation of a board meeting in which Sergey Goncharevich took part as a speaker. He invited participants to decide on the …

Serge Hancharevich, Managing Partner of Capital Times, spoke at the final of the CGPA Corporate Director program Read More »

Capital Times Investment Advisory Closes Deals for $ 500 million in Total Value Over the Last 15 Years. How the Company transformed after its partners split the business.

What is the future of M&A advisory for Capital Times amid a concerning trend when medium-size businesses try to perform M&A deals in-house? Read the article in Forbes In March 2020, Serge Hancharevich, managing partner of Capital Times faced a new challenge. It wasn’t just the COVID-19 pandemic-related problems. Serge had to split the Company with his …

Capital Times Investment Advisory Closes Deals for $ 500 million in Total Value Over the Last 15 Years. How the Company transformed after its partners split the business. Read More »

Lazard Global Healthcare Leaders Study 2021

This year’s Study by the investment bank Lazard focused both on challenges and expectations of industry leaders related to the pandemic and their overall strategic priorities for the pharmaceutical business. 171 C-level executives and 29 investors across 3 pharmaceutical sectors as Biopharmaceutical, Medical Devices and Diagnostics, and Healthcare Services were interview during the Survey. Read …

Lazard Global Healthcare Leaders Study 2021 Read More »